Mereo BioPharma Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.About MREO
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).
CEODenise Vera Scots-Knight
CEODenise Vera Scots-Knight
Employees39
Employees39
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2015
Founded2015
Employees39
Employees39
MREO Key Statistics
Market cap45.78M
Market cap45.78M
Price-Earnings ratio-1.66
Price-Earnings ratio-1.66
Dividend yield—
Dividend yield—
Average volume839.24K
Average volume839.24K
High today$0.30
High today$0.30
Low today$0.2833
Low today$0.2833
Open price$0.2876
Open price$0.2876
Volume381.74K
Volume381.74K
52 Week high$2.37
52 Week high$2.37
52 Week low$0.20
52 Week low$0.20
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
16.7%
Sell
16.7%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.